Pfizer inks deal to buy Excaliard
Pfizer Inc. has agreed to acquire Excaliard Pharmaceuticals Inc., a privately owned biopharmaceutical company focused on developing novel drugs for the treatment of skin fibrosis, or skin scarring.
Supplier News
Gilead to acquire Pharmasset for $11 billion
Gilead Sciences Inc. plans to buy Pharmasset Inc. in a cash deal valued at about $11 billion Gilead said Monday that the acquisition will accelerate the development of an all-oral regimen for the treatment of the chronic hepatitis C virus (HCV). The companies said the combination also will
Fixodent ‘challenges’ denture wearers
Fixodent Original is putting consumers to the test with the Fixodent 12 Hour Hold Challenge. The Procter & Gamble denture adhesive brand said that through June 30, 2012, it is encouraging consumers to submit written testimonials sharing their own personal denture challenges.
Cold-EEZE wins seal of approval
Cold-EEZE, a homeopathic cold remedy, has been awarded the Parent Tested Parent Approved Winner’s Seal of Approval. ProPhase Labs, the maker of Cold-EEZE, said the PTPA seal of approval was awarded based on quality, effectiveness and value.
Pfizer’s Advil aims to relieve congestion in communities
Pfizer Consumer Healthcare has kicked off the Advil Congestion Relief Project, an effort to alleviate real problems in communities nationwide. Yankees outfielder Brett Gardner helped unveil a new library in the Bronx, N.Y., at the first stop of the Advil Congestion Relief Project.
Perrigo plans store-brand gentle baby formula
Perrigo Co. has been approved by the Food and Drug Administration to market and distribute infant formula containg 100% partially hydrolyzed whey protein.
CCA adds to sales team
Michael Piff has been named executive vice president of sales at CCA Industries Inc. The health and beauty care product developer and marketer said Tuesday that Piff joined the company earlier this month and will be based at its East Rutherford, N.J., headquarters.
Dream Water lands distribution pact with CVS
Dream Products LLC has entered a national retail alliance with CVS/pharmacy to distribute its Dream Water sleep aid in the sleep section of CVS drug stores. The company said Tuesday that not even two years after its launch at retail, the Dream Water sleep enhancer has become part of the mix in more
Qualitest gets FDA OK for pain reliever
Qualitest Pharmaceuticals has received approval from the Food and Drug Administration to market acetaminophen and codeine phosphate oral solution, 120mg/12mg per 5ml.
Watson releases generic version of Kadian
Watson Pharmaceuticals Inc. has begun shipping morphine sulfate extended-release capsules. The company said Thursday it has received approval from the Food and Drug Administration for its abbreviated new drug application (ANDA) for the product, a generic equivalent of Actavis’ Kadian.
Salix inks deal to buy Oceana Therapeutics
Salix Pharmaceuticals Ltd. plans to acquire Oceana Therapeutics Inc. for $300 million in cash. Under the acquisition agreement announced this week, Salix will purchase all of the outstanding stock of Oceana, a global provider of gastroenterology and urology therapeutics.
Kimberly-Clark recalls Kotex tampons from some stores
Kimberly-Clark has initiated a product recall of a limited number of its Kotex Natural Balance Security Unscented Tampons Regular Absorbency that were distributed to specific stores in the United States.
Energizer general counsel to retire; successor appointed
Energizer Holdings Inc. announced that Gayle Stratmann, vice president and general counsel, is retiring from the company next year. Energizer said Tuesday that plans call for Stratmann, who has held that post since March 2003, to retire in the first half 2012.
Ivory names celebrity spokesperson, launches social site
Procter & Gamble soap brand Ivory has named television actress Melissa McCarthy as the brand spokesperson and host of its new online social community, called Soap Dish.
Perrigo, Sython launch Xyzal oral solution generic
Perrigo Co. and its partner Synthon Pharmaceuticals Inc. announced that Perrigo has begun shipping levocetirizine solution, 2.5 mg/5ml. Perrigo said Monday that the product is a generic version of UCB’s Xyzal Oral Solution, indicated for the treatment of indoor and outdoor allergies.